4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000059
EVP, Chief Development Officer sold 7,072 shares at $32.86 ($232,407)
- EVP, Chief Development Officer acquired 18,901 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Geary Richard S · EVP, Chief Development Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-15 | Exercise or conversion : show line 1 in the form | +18,901 | 103,735 | D | ||
| 2025-01-16 | Sale : show line 2 in the form | −7,072 | $32.86 | $232,407 | 96,663 | D |
| Open-market sales · 7,072 sh · avg $32.86 · $232,407 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-15 | Grant or award : show line 3 in the form Performance Restricted Stock Units | +22,000 | 64,801 | D |
| 2025-01-15 | Grant or award : show line 4 in the form Restricted Stock Unit | +33,000 | 79,625 | D |
| 2025-01-15 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −18,901 | 60,724 | D |
Loading xslF345X05/edgardoc.xml…